Skip to main content
OpenTrials

Clinical trial condition

Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations

Explore clinical trials studying Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations trial results

Recruiting

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

NCT05967689

Conditions
Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations, Carcinoma, Lung Diseases, +4 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope - Duarte Duarte, California, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Comprehensive Cancer Centers of Nevada - Central Valley - Twain Las Vegas, Nevada, United States
View all 80 locations
View Trial Details

Related conditions